Results of the QIS5 Report

Size: px
Start display at page:

Download "Results of the QIS5 Report"

Transcription

1 aktuariat-witzel Universität Basel Frühjahrssemester 2011 Dr. Ruprecht Witzel

2 On 5 July 2010 the European Commission published the QIS5 Technical Specifications The calculations were done in the second half of the year 2010 The reporting date to be used by all participants should be end December 2009 On 14 March 2011 the European Insurance and Occupational Pensions Authority (EIOPA) published the Report on the fifth Quantitative Impact Study (QIS5) for Solvency II This presentation summarizes the main results of this report Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 2

3 Content 1. Introduction 2. Overall Financial Impact 3. Valuation of Assets and other Liabilities 4. Technical Provisions 5. SCR Standard Formula 6. SCR Internal Model 7. MCR 8. Own Funds Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 3

4 1. Introduction 1.3. Objectives The results of QIS5 are intended to be of use in the European Commission s development of level 2 implementing measures. To try to ensure that the results provided a representative view, the target participation rates were significantly increased from previous QIS exercises. There was a particular emphasis on increasing participation among small and medium-sized (re)insurance undertakings. QIS5 aimed to obtain detailed information on the quantitative impact of the proposals on insurers and reinsurers solvency balance sheets and also to check that the proposals were aligned with the principles and calibration targets set out in the Solvency II Framework Directive. Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 4

5 1. Introduction 1.3. Objectives It was also the intention to encourage undertakings and supervisors to prepare for the introduction of Solvency II and identify areas where further preparatory work may be required, and to provide a starting point for ongoing dialogue between supervisors and the industry as we move towards Solvency II implementation. Finally, it would also allow EIOPA to assess the feasibility and complexity of the proposals. Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 5

6 1. Introduction 1.4. Participation 77% of the 4753 European (re)insurers supervised by EIOPA members and observers at end 2009 will be affected by the Solvency II directive. A thousand existing small undertakings are expected not to fall into the scope of the directive. 68% of the affected (re)insurers participated on a voluntary basis in the fifth quantitative impact study. 167 groups, including major groups active on a worldwide basis as well as groups with business concentrated in a few or even a single EEA market, provided input allowing policy-makers to better understand the impact of the Solvency II proposals on a consolidated basis. Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 6

7 1. Introduction 1.4. Participation This report focuses on the quantitative and qualitative responses of the 2520 (re)insurers and 167 groups which provided usable information. Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 7

8 1. Introduction 1.4. Participation Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 8

9 1. Introduction 1.4. Participation Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 9

10 Content 1. Introduction 2. Overall Financial Impact 3. Valuation of Assets and other Liabilities 4. Technical Provisions 5. SCR Standard Formula 6. SCR Internal Model 7. MCR 8. Own Funds Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 10

11 2. Overall Financial Impact 2.1. Overall Surplus Since the previous QIS, which was run on end 2007 accounts, the insurance sector financial surplus under the current solvency regime has seen a marked decrease in 2008 (of the order of 200bn) - followed by a partial recovery in This evolution is largely explained by the impact the financial crisis had on the value of assets owned by the sector, and on interest rates used to discount liabilities in some countries. At the end of 2009 the surplus was approximately 500bn. Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 11

12 2. Overall Financial Impact 2.1. Overall Surplus Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 12

13 2. Overall Financial Impact 2.1. Overall Surplus The Solvency II framework replaces the existing solvency requirement with a set of two financial requirements: a threshold triggering immediate and ultimate supervisory action named the Minimum Capital Requirement (MCR) and a higher, risk-sensitive capital requirement named the Solvency Capital Requirement (SCR). Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 13

14 2. Overall Financial Impact 2.1. Overall Surplus The Solvency Capital Requirement (SCR) is defined as the potential amount of own funds that would be consumed by unexpected large events whose probability of occurrence within a one year time frame is 0.5%. This definition based on a probability measure allows (and sometimes mandates) the replacement of all or part of the standard formula with an internal model, when this can be shown to be better able to fulfill the directive requirements in relation to an undertaking s particular risk profile. Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 14

15 2. Overall Financial Impact 2.1. Overall Surplus The Minimum Capital Requirement (MCR) is defined as the potential amount of own funds that would be consumed by unexpected events whose probability of occurrence within a one year time frame is 15%. In order to ensure the smooth functioning of graduated supervisory intervention (often referred to as the ladder of intervention ), the linear result produced by the MCR calculation is bounded between 25% and 45% of the SCR, subject to an absolute minimum. Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 15

16 2. Overall Financial Impact 2.1. Overall Surplus The following graph shows the overall quantitative effect of the switch from the current requirements to the two Solvency II capital thresholds as specified under QIS5. Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 16

17 2. Overall Financial Impact 2.1. Overall Surplus Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 17

18 2. Overall Financial Impact 2.1. Overall Surplus The financial position of the European insurance sector remains comfortable assessed against the standard formula SCR calculated according to the QIS5 specifications, with the eligible amount of own funds to cover the SCR/MCR exceeding the regulatory requirements by around 360bn. This surplus has decreased by c. 120bn compared to the current regime. At the same time, the margin before the MCR, the point of mandatory supervisory intervention, has increased by 200bn. Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 18

19 2. Overall Financial Impact 2.1. Overall Surplus Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 19

20 2. Overall Financial Impact 2.1. Overall Surplus Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 20

21 2. Overall Financial Impact 2.1. Overall Surplus Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 21

22 2. Overall Financial Impact 2.1. Overall Surplus Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 22

23 2. Overall Financial Impact 2.3. The main drivers of the surplus changes Three main drivers explain the changes in the surplus from the current regime to the Solvency II framework: the shift from the current balance sheet to the harmonized Solvency II balance sheet; the shift from the current requirements to the harmonized Solvency II capital requirements; and the differences in the own funds elements allowed to cover the requirements. The following graph shows the respective influence of these items, splitting the valuation impacts into positive and negative effects. As this revaluation changes the amount of own funds compared to the current situation, it also creates deferred tax assets or liabilities. Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 23

24 2. Overall Financial Impact 2.3. The main drivers of the surplus changes Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 24

25 2. Overall Financial Impact 2.4. Impact of diversification To calculate the Solvency II capital requirement, which is defined at the overall SCR level, the standard formula applies a modular bottom-up approach in which each of the underlying risk drivers is modeled using the same calibration as that set by the directive for the overall result. For QIS5, the sum of the individual risks modeled totaled more than 1300bn. To acknowledge the fact that the individual risks are not all expected to materialize at the same time (e.g. a shock on financial markets and a loss on underwriting risks would not necessarily crystallize at the same time), the standard formula recognizes the benefits of risk diversification through the use of linear correlation techniques. Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 25

26 2. Overall Financial Impact 2.4. Impact of diversification For QIS5, these diversification benefits amounted to a 466bn reduction in the total risk charge at solo level. The last stage in the derivation of the SCR recognizes that if risks were to materialize, part of their cost might be transferred onto policyholders (e.g. through a reduction in the bonuses attributed to policies with profit participation), and part of the remaining cost might result in a reduction in the future taxes expected to be paid to tax authorities. For QIS5, the expected sharing of the cost of risk crystallization with policyholders and tax authorities resulted in a 314bn reduction in the own funds needed. Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 26

27 2. Overall Financial Impact 2.4. Impact of diversification Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 27

28 2. Overall Financial Impact 2.4. Impact of diversification Overall, the final SCR of 547bn is a little above 41% of the sum of individual risks modeled. Using this overall risk reduction as a basis for calculating the reduction in individual risks gives a rough idea of the average real risk charges. Using this simple approach would for example show that while the initial risk loading for listed equity in QIS5 was 30% of the equity exposure, the final risk capital required was on average equivalent to a 12.4% capital charge. Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 28

29 Content 1. Introduction 2. Overall Financial Impact 3. Valuation of Assets and other Liabilities 4. Technical Provisions 5. SCR Standard Formula 6. SCR Internal Model 7. MCR 8. Own Funds Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 29

30 3. Valuation of Assets and other Liabilities 3. Valuation of Assets and other Liabilities Outlined below is the composition of the balance sheet, for both solo undertakings and groups, and under the valuation principles of QIS5 and the current accounting regime. Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 30

31 3. Valuation of Assets and other Liabilities The current balance sheet (solo) Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 31

32 3. Valuation of Assets and other Liabilities The current balance sheet (solo) Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 32

33 3. Valuation of Assets and other Liabilities The QIS5 balance sheet (solo) Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 33

34 3. Valuation of Assets and other Liabilities The QIS5 balance sheet (solo) Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 34

35 3. Valuation of Assets and other Liabilities 3.1. General In general the QIS5 economic valuation requirements for assets and other liabilities were supported and did not cause many problems. Because of the similarity with EU endorsed international accounting standards (IFRS) many undertakings have experience with most of the valuation requirements. This is especially the case for undertakings that use IFRS or undertakings that use local GAAP in countries where the local accounting principles are similar to IFRS valuation principles. Countries where local accounting principles differ significantly from IFRS and where assets are valued on a cost basis reported more problems and some doubts about the reliability of the reported QIS5 balance sheet. Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 35

36 3. Valuation of Assets and other Liabilities 3.5. Intangible Assets Most intangibles were valued at nil in the QIS5 balance sheet. Some undertakings valued software as an intangible asset, often justifying this with reference to the valuation in IAS 38 or local accounting standards. A couple of undertakings recognised intangibles in respect of renewal rights and customer relationships, consistent with their audited financial statements. Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 36

37 Content 1. Introduction 2. Overall Financial Impact 3. Valuation of Assets and other Liabilities 4. Technical Provisions 5. SCR Standard Formula 6. SCR Internal Model 7. MCR 8. Own Funds Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 37

38 4. Technical Provisions 4. Technical Provisions Under Solvency II, the valuation of technical provisions follows the transfer value principle, under which the value of technical provisions shall correspond to the current amount the insurer would have to pay if was to transfer its insurance obligations immediately to another insurer. To achieve a valuation consistent with this principle, the technical provisions are calculated as a best estimate plus a risk margin. The best estimate corresponds to the probabilityweighted average of future cash-flows, taking account of the time value of money. Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 38

39 4. Technical Provisions 4. Technical Provisions The risk margin represents the cost of providing an amount of eligible own funds equal to the Solvency Capital Requirement necessary to support the insurance and reinsurance obligations over the lifetime thereof. Net technical provisions refers to technical provisions net of reinsurance recoverables. Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 39

40 4. Technical Provisions 4.1. Comparison with current regime Overall gross technical provisions for all lines of business decreased by 1.4% from Solvency I to QIS5. The main differences between technical provisions under the QIS5 and Solvency I methodologies can be explained by the following: the use of a new discounting model including the use of an illiquidity premium; the absence of any surrender floor; the recognition of future premiums and charges; and the use of realistic assumptions in the best estimate calculation (i.e. no implicit prudence margin, although this is partly offset by the inclusion of an explicit risk margin in addition to the best estimate). Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 40

41 4. Technical Provisions 4.1. Comparison with current regime In the valuation of QIS5 liabilities, management actions and policyholders behavior, such as lapses, renewals and surrenders, were taken into account. Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 41

42 4. Technical Provisions 4.1. Comparison with current regime For life insurance business net technical provisions in QIS5 increased in comparison with Solvency I. This was mainly caused by the decrease in reinsurance recoverables, as gross technical provisions in fact showed a slight decrease of 1.0%. The graph below shows a comparison of life net provisions for all QIS5 participants under QIS5 and Solvency I. We note that total net provisions are greater under QIS5 than under Solvency I and that this is an increase of around 3% (for solo undertakings). Net provisions for with profit business increased by 8% under the new regime. Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 42

43 4. Technical Provisions 4.1. Comparison with current regime Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 43

44 4. Technical Provisions 4.1. Comparison with current regime For most non-life lines of business net provisions have decreased from Solvency I to QIS5; gross provisions for non-life decreased by 24.9%. Please note that equalization reserves can no longer be included in the technical provisions. The decrease between Solvency I and QIS5 for non-life business is mainly due to the discounting of future cash flows, and the exclusion of the implicit safety margin included in technical provisions through prudent and cautious assumptions, partially offset by the inclusion of an explicit risk margin. The observed changes could also be partially due to different segmentations between the two regimes. Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 44

45 4. Technical Provisions 4.1. Comparison with current regime Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 45

46 4. Technical Provisions 4.2. Discount rate and illiquidity premium General Comment Based on the amount of the illiquidity premium risk submodule in the SCR, which corresponds to a reduction of 65% of the illiquidity premium included in the valuation of technical provisions, the effect of the introduction of the illiquidity premium in the valuation of technical provisions in QIS5 can be estimated as being almost 1% of the value of technical provisions (which represents around 15% of SCR). Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 46

47 4. Technical Provisions 4.2. Discount rate and illiquidity premium 50% Bucket The most common products where 50% of the illiquidity premium was used were nonlife in general, unit- and index-linked business, life without profit participation, SLT (Similar to Life Techniques) health, non-slt health and reinsurance (both life and non-life). Some undertakings also used 50% of the illiquidity premium for life insurance with profit participation, pure savings products and longevity swaps. Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 47

48 4. Technical Provisions 4.2. Discount rate and illiquidity premium 75% Bucket The most common products where 75% of the illiquidity premium was used were life insurance with profit participation in general, pure savings products, unitand index-linked insurance with guarantees, and various types of annuities. Some undertakings also used the 75% bucket for SLT health, non-life, non-slt health, life reinsurance, annuities from non-life, and life insurance without profit participation. Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 48

49 4. Technical Provisions 4.2. Discount rate and illiquidity premium 100% Bucket The most common products where 100% of the illiquidity premium was used were different types of annuities (including annuities from non-life). 100% of the illiquidity premium was also used for retirement business in run-off, unit-linked insurance, nonlife insurance, and non-slt health insurance. Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 49

50 4. Technical Provisions 4.2. Discount rate and illiquidity premium Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 50

51 4. Technical Provisions 4.3. Risk margin Very few undertakings across Europe reported having used the full calculation approach for the valuation of the risk margin. Almost all supervisors noted that a full calculation was often too complex and time-consuming for undertakings. Undertakings have therefore largely used the proposed simplifications. Because the calculation was so burdensome, supervisory authorities often supported the use of simplifications, some of them also pointing out that the relative immateriality of the risk margin means that it does not justify such difficult calculations. Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 51

52 4. Technical Provisions 4.3. Risk margin As shown in the graph, for EEA solo undertakings the risk margin is higher as a proportion of net best estimate for business without profit participation compared to other lines of business. For some non-life lines of business the ratio is a bit higher than 10%. Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 52

53 4. Technical Provisions 4.3. Risk margin Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 53

54 4. Technical Provisions 4.3. Risk margin Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 54

55 4. Technical Provisions 4.3. Risk Margin The following two graphs (above) show the percentage of total provisions which could not be reliably replicated by assets with an observable market value, and which were calculated as a best estimate plus risk margin. They show that the percentage of technical provisions calculated as a whole (those which could be reliably replicated by assets with an observable market value) in QIS5 is almost nil in non-life, while it is material in life, especially in reinsurance. Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 55

56 4. Technical Provisions 4.3. Risk margin Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 56

57 4. Technical Provisions 4.3. Risk margin Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 57

58 4. Technical Provisions 4.4. Segmentation Life Almost all countries reported difficulties with the second level of segmentation (death, survival, disability/morbidity, saving). The main issue is the idea that a contract is classified according to the main risk driver at inception of the policy and does not need to be reclassified over the life of the policy. Undertakings were of the view that this approach materially distorts the picture, as the nature of a policy changes over time. Some life undertakings indicated their support for segmentation according to the relevant risk at reporting date. Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 58

59 4. Technical Provisions 4.4. Segmentation Life Moreover undertakings in several countries reported that it was unclear when to unbundle a contract. A few countries reported problems with the segmentation of some hybrid contracts (e.g. unit-linked products combined with guarantees). Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 59

60 4. Technical Provisions 4.4. Segmentation Non-Life Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 60

61 Content 1. Introduction 2. Overall Financial Impact 3. Valuation of Assets and other Liabilities 4. Technical Provisions 5. SCR Standard Formula 6. SCR Internal Model 7. MCR 8. Own Funds Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 61

62 5. SCR Standard Formula 5.1. The overall SCR The Solvency Capital Requirement (SCR) is the riskbased capital requirement for undertakings under Solvency II. It is calibrated to a 99.5% Value at Risk confidence level over one year. In structure the SCR is composed of a number of modules which in turn are composed of sub-modules. The capital requirements arising from these submodules and modules are aggregated using a correlation matrix. Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 62

63 5. SCR Standard Formula 5.1. The overall SCR (all; SCR = 100%) Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 63

64 5. SCR Standard Formula 5.1. The overall SCR (all; BSCR = 100%) Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 64

65 5. SCR Standard Formula 5.1. The overall SCR (all; SCR in % of BSCR) Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 65

66 5. SCR Standard Formula 5.1. The overall SCR (Life; BSCR = 100%) Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 66

67 5. SCR Standard Formula 5.1. The overall SCR (Non-Life; BSCR = 100%) Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 67

68 5. SCR Standard Formula 5.5. Market risk (all; Market Risk = 100%) Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 68

69 5. SCR Standard Formula 5.7. Life Underwriting risk (all; Life Risk = 100%) Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 69

70 5. SCR Standard Formula 5.7. Life Underwriting risk (Life; Life Risk = 100%) Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 70

71 5. SCR Standard Formula 5.9. Non-life Underwriting risk (Non-L; Non-Life Risk = 100%) Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 71

72 Content 1. Introduction 2. Overall Financial Impact 3. Valuation of Assets and other Liabilities 4. Technical Provisions 5. SCR Standard Formula 6. SCR Internal Model 7. MCR 8. Own Funds Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 72

73 6. SCR Internal Models 6.2. Current status of internal modeling in the EEA Participants reported the following main reasons for using internal models instead of the standard formula: internal models better reflect the undertakings specific risk profiles, additional risks are covered by the internal model beyond those covered by the standard formula; the internal model applies a more granular aggregation method than the standard formula; the standard formula does not take into account volatility; and to use IFRS valuation rules instead of QIS5. Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 73

74 6. SCR Internal Models 6.2. Current status of internal modelling in the EEA In relation to the last comment, we note that internal models may be used to calculate the SCR but should not change the approach to valuation. Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 74

75 6. SCR Internal Models 6.3. General comparison of the internal model results with the standard formula The overall SCR results are regarded in this report as the most comparable figure for analysis because it should include all risk factors and adjustments. In QIS5 234 undertakings (about 10% of all participating undertakings) provided overall SCR results calculated by internal models. It should be emphasized that this meant EIOPA could not prepare detailed analysis of internal model results across the EEA. Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 75

76 6. SCR Internal Models 6.3. General comparison of the internal model results with the standard formula Comparison of the internal model SCR and the standard formula SCR (based on the small sample) demonstrates the impact which internal models have on the final capital requirement. The table shows that the median of the SCR ratio across all undertakings was 91% and the weighted average was 99%. On average in the figures provided by undertakings the internal model results were very close to those derived by the standard formula; however, there was variation at individual level. Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 76

77 6.3. General comparison of the internal model results with the standard formula. 6. SCR Internal Models Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 77

78 Content 1. Introduction 2. Overall Financial Impact 3. Valuation of Assets and other Liabilities 4. Technical Provisions 5. SCR Standard Formula 6. SCR Internal Model 7. MCR 8. Own Funds Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 78

79 7. MCR 7.1. MCR calculation In general no major practical difficulties in calculating the MCR were mentioned by undertakings. There were a number of comments about the lack of risk sensitivity in the MCR, with a small minority of countries proposing it be set to a fixed proportion of the SCR. Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 79

80 7. MCR 7.2. MCR corridor The MCR was subject to a corridor of between 25% and 45% of SCR, in order to ensure an adequate ladder of supervisory intervention in all cases. At EEA level 35% of undertakings MCRs are already within the corridor and are thus unaffected by it. The MCRs of 41% of undertakings are subject to the lower limit while 23% of undertakings MCRs are caught by the upper limit, giving the combined distribution below. Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 80

81 7. MCR 7.2. MCR corridor Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 81

82 7. MCR 7.3. AMCR As well as the adjustment for the corridor, there was also a requirement that the MCR be greater than the AMCR (Absolute Minimum Capital Requirement) levels set for nonlife, life and composite undertakings respectively. Examples: 2.2m for Non-Life insurance companies 3.2m for Life insurance companies 3.2m for reinsurance companies For almost 15% of participants across Europe, this resulted in a final MCR above the 45% cap, and for 6.6% of undertakings, this final MCR was higher than their SCR. Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 82

83 7. MCR 7.3. AMCR Some countries were concerned by this last group, and questioned how the ladder of supervisory intervention would apply if there was only the hard limit of the MCR, without the additional limit of the SCR above it. Some supervisors commented that a number of the undertakings which failed to meet their MCR were undertakings which would have been able to meet their calculated MCR, were it not for the AMCR coming into play and raising this higher. Also on the AMCR, a few countries proposed that clarification on indexation and exchange rates for non-euro AMCR will be needed going forwards. Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 83

84 Content 1. Introduction 2. Overall Financial Impact 3. Valuation of Assets and other Liabilities 4. Technical Provisions 5. SCR Standard Formula 6. SCR Internal Model 7. MCR 8. Own Funds Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 84

85 8. Own Funds 8.1. Composition of Own Funds Under Solvency II there are two types of own funds: basic own funds on the balance sheet and ancillary own funds which are items which can be called up to absorb losses. Basic own funds comprise the excess of assets over liabilities which is broadly represented by ordinary share capital, the equivalent for mutual and mutual type undertakings and reserves together with subordinated liabilities. Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 85

86 8. Own Funds 8.1. Composition of Own Funds The tiering system categorizes the own funds items according to their loss absorbing characteristics. Various adjustments are made to take into account restrictions on the availability of own funds items, in order to arrive at the amount available to meet the Solvency II capital requirements. A system of limits establishes the amount of own funds eligible to meet the SCR and MCR respectively. Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 86

87 8. Own Funds 8.1. Composition of Own Funds Available own funds amount to 921bn in total. Of this 846bn represents the highest quality Tier 1, which does not have any restrictions on its use to meet the SCR/MCR. A breakdown of the available own funds is below. From this it can be seen that the majority is basic own funds with ancillary own funds representing only 1.3%. Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 87

88 8. Own Funds 8.1. Composition of Own Funds Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 88

89 8. Own Funds 8.2. Unrestricted Tier 1 This represents the highest quality own funds and accounts for 91.9% of available own funds (for groups 81.5%). QIS5 analyses the components of unrestricted Tier 1 by extracting the accounting balance sheet values for ordinary share capital, mutuals initial fund, share premium, retained earnings and other reserves appearing in the accounts. Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 89

90 8. Own Funds 8.2. Unrestricted Tier 1 Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 90

91 8. Own Funds 8.5. Adjustments to Basic Own Funds These can arise in relation to ring-fenced funds, restricted reserves, participations in financial and credit institutions and net deferred tax assets. The nature and quantum of the various adjustments are set out in the chart below. Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 91

92 8. Own Funds 8.5. Adjustments to Basic Own Funds Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 92

93 8. Own Funds 8.6. Ancillary Own Funds Ancillary own funds (AOF) as off-balance-sheet capital represent one of the key developments of Solvency II. Under the Solvency I regime certain items form part of the available solvency margin but will be treated as AOF under Solvency II. These are generally specific to certain market sectors a good example is the calls which mutuals may make on their members. A more general framework for off-balance sheet items extends the potential for undertakings to use such items although it is not clear to what extent they will seek to make use of AOF once Solvency II is implemented. Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 93

94 8. Own Funds 8.6. Ancillary Own Funds The nature of AOF means that there must be the safeguard of supervisory approval, as specified in the Framework Directive, before such items can be counted towards the SCR. AOF are classified as ancillary tier 2 if on being called up and paid in they become tier 1 or otherwise as ancillary tier 3. Ancillary tier 2 amounted to 11.6bn spread over thirteen countries of which 10.5bn was accounted for by three countries. Ancillary tier 3 was much less significant, with 0.1bn reported over four countries. Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 94

95 8. Own Funds 8.6. Ancillary Own Funds The graph below provides a breakdown of these amounts by type of ancillary own funds. A significant amount of the ancillary tier 2 represents letters of credit and guarantees held in trust by an independent trustee, as envisaged under article 96 (2) of the Framework Directive, together with supplementary calls by mutual and mutual type organizations, also referred to in article 96. Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 95

96 8. Own Funds 8.6. Ancillary Own Funds Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 96

97 8. Own Funds 8.7. EPIFP QIS5 required the identification and calculation of an amount representing expected profits included in future premiums (EPIFP) and its disclosure as a separate item under unrestricted Tier 1. For this purpose future premiums are those taken into account as part of the cash inflows used to determine technical provisions under Solvency II. The identification of an EPIFP amount as a component of the excess of assets over liabilities within Tier 1 is intended to inform the continuing policy debate and Level 2 negotiations. Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 97

98 8. Own Funds 8.7. EPIFP Of 2520 undertakings participating in QIS5 745 (29%) identified EPIFP. Across the different countries there was significant variation in levels of completion, ranging from nil to 80% with an average across Member States of 34%. Five countries accounted for 70% of the EPIFP total amount of 83.7bn. Putting these amounts in context the weighted average percentage of EPIFP to Tier 1 among undertakings was 20% with a median of 14%. Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 98

99 8. Own Funds 8.7. EPIFP However it should be noted that the Tier 1 attributable to the undertakings which did identify EPIFP represents 45% of Tier 1 for QIS5 as a whole indicating that this group is drawn from larger undertakings. Not surprisingly EPIFP is a more important component of own funds for life and health insurers as compared to non-life insurers. As emphasized above though, results should be treated carefully, as they differ greatly between undertakings and countries. Furthermore, from the qualitative responses it appears that many non-life undertakings did not engage with this part of QIS5 or assumed it was relatively insignificant. Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS 11 99

100 8. Own Funds 8.7. EPIFP Akt. Contr II Solvenz 8. Results QIS5 Dr. Ruprecht Witzel; FS

Results of the QIS5 Report Short Version

Results of the QIS5 Report Short Version aktuariat-witzel Results of the QIS5 Report Short Version Universität Basel Frühjahrssemester 2013 Dr. Ruprecht Witzel ruprecht.witzel@aktuariat-witzel.ch On 5 July 2010 the European Commission published

More information

Hot Topic: Understanding the implications of QIS5

Hot Topic: Understanding the implications of QIS5 Hot Topic: Understanding the 17 March 2011 Summary On 14 March 2011 the European Insurance and Occupational Pensions Authority (EIOPA) published the results of the fifth Quantitative Impact Study (QIS5)

More information

The Solvency II project and the work of CEIOPS

The Solvency II project and the work of CEIOPS Thomas Steffen CEIOPS Chairman Budapest, 16 May 07 The Solvency II project and the work of CEIOPS Outline Reasons for a change in the insurance EU regulatory framework The Solvency II project Drivers Process

More information

Solvency II, messages and findings from QIS 5. Carlos Montalvo Rebuelta Executive Director Brussels, 7 March 2011

Solvency II, messages and findings from QIS 5. Carlos Montalvo Rebuelta Executive Director Brussels, 7 March 2011 Solvency II, messages and findings from QIS 5 Carlos Montalvo Rebuelta Executive Director Brussels, 7 March 2011 Index Preparedness of Insureres and Supervisors Impact of the proposed regime Feasibility

More information

COVER NOTE TO ACCOMPANY THE DRAFT QIS5 TECHNICAL SPECIFICATIONS

COVER NOTE TO ACCOMPANY THE DRAFT QIS5 TECHNICAL SPECIFICATIONS EUROPEAN COMMISSION Internal Market and Services DG FINANCIAL INSTITUTIONS Insurance and Pensions 1. Introduction COVER NOTE TO ACCOMPANY THE DRAFT QIS5 TECHNICAL SPECIFICATIONS Brussels, 15 April 2010

More information

An Introduction to Solvency II

An Introduction to Solvency II An Introduction to Solvency II Peter Withey KPMG Agenda 1. Background to Solvency II 2. Pillar 1: Quantitative Pillar Basic building blocks Assets Technical Reserves Solvency Capital Requirement Internal

More information

Solvency II Update. Latest developments and industry challenges (Session 10) Réjean Besner

Solvency II Update. Latest developments and industry challenges (Session 10) Réjean Besner Solvency II Update Latest developments and industry challenges (Session 10) Canadian Institute of Actuaries - Annual Meeting, 29 June 2011 Réjean Besner Content Solvency II framework Solvency II equivalence

More information

Financial Assurance Company Limited

Financial Assurance Company Limited Financial Assurance Company Limited Solvency and Financial Condition Report Disclosures 31 December 2016 (Monetary amounts in GBP thousands) General information Undertaking name Financial Assurance Company

More information

Essential adjustments for the success of Solvency II for groups

Essential adjustments for the success of Solvency II for groups Position Paper Essential adjustments for the success of Solvency II for groups (based on the findings from QIS5 for groups and the current discussion on implementing measures) CEA reference: ECO-SLV-11-729

More information

Cirencester Friendly Society Limited Solvency and Financial Condition Report Disclosures 31 December 2016 (Monetary amounts in GBP thousands) General information Undertaking name Cirencester Friendly Society

More information

REQUEST TO EIOPA FOR TECHNICAL ADVICE ON THE REVIEW OF THE SOLVENCY II DIRECTIVE (DIRECTIVE 2009/138/EC)

REQUEST TO EIOPA FOR TECHNICAL ADVICE ON THE REVIEW OF THE SOLVENCY II DIRECTIVE (DIRECTIVE 2009/138/EC) Ref. Ares(2019)782244-11/02/2019 REQUEST TO EIOPA FOR TECHNICAL ADVICE ON THE REVIEW OF THE SOLVENCY II DIRECTIVE (DIRECTIVE 2009/138/EC) With this mandate to EIOPA, the Commission seeks EIOPA's Technical

More information

2016 Public Quantitative Reporting Templates Solvency II Aegon Spaarkas N.V.

2016 Public Quantitative Reporting Templates Solvency II Aegon Spaarkas N.V. 216 Public Quantitative Reporting Templates Solvency II N.V. This document contains the following quantitative reporting templates (QRTs) which relate to the position at 31 December 216: S.2.1.2 Balance

More information

DISCLOSURE QRT REPORT Proteq Levensverzekeringen 2017

DISCLOSURE QRT REPORT Proteq Levensverzekeringen 2017 DISCLOSURE QRT REPORT Proteq Levensverzekeringen 2017 S.02.01 - Balance Sheet S.02.01... 2 S.05.01 - Premiums, claims and expenses by line of business S.05.01... 3 S.05.02 - Premiums, claims and expenses

More information

Table of content Disclosure QRT's Proteq Levensverzekeringen NV

Table of content Disclosure QRT's Proteq Levensverzekeringen NV Table of content Disclosure QRT's Proteq Levensverzekeringen NV 1 Balance Sheet 2 Premiums, claims and expenses by line of business 3 Premiums, claims and expenses by country 4 Life and Health SLT Technical

More information

Solvency II. New Rules in Europe for the Insurance Industry. Lecture at UConn Law, January 28, 2013

Solvency II. New Rules in Europe for the Insurance Industry. Lecture at UConn Law, January 28, 2013 Solvency II New Rules in Europe for the Insurance Industry Lecture at UConn Law, January 28, 2013 Christian Armbrüster Freie Universität Berlin c.armbruester@fu-berlin.de Main institutions of the European

More information

QRT Appendix S.02.01.02 Balance sheet Solvency II Value Statutory accounts value Assets C0010 C0020 R0010 Goodwill - R0020 Deferred acquisition costs 208.073 R0030 Intangible assets - 1.349.412 R0040 Deferred

More information

RAPPORT SUR LA SOLVABILITE ET LA SITUATION FINANCIERE

RAPPORT SUR LA SOLVABILITE ET LA SITUATION FINANCIERE RAPPORT SUR LA SOLVABILITE ET LA SITUATION FINANCIERE Cardif Assurances Risques Divers Annexes Quantitative Reporting Templates - QRT 31 décembre 2016 Balance sheet S.02.01.21 Solvency II value C0010 Assets

More information

5 S Calculation of Solvency Capital Requirement

5 S Calculation of Solvency Capital Requirement S.No Table Code Table Label 1 S.02.01.01.01 Balance sheet 2 S.23.01.01.01 Own funds 3 S.23.01.01.02 Reconciliation reserve 4 S.25.01.01.01 Basic Solvency Capital Requirement 5 S.25.01.01.02 Calculation

More information

2016 Public Quantitative Reporting Templates Solvency II Aegon Levensverzekering N.V.

2016 Public Quantitative Reporting Templates Solvency II Aegon Levensverzekering N.V. 216 Public Quantitative Reporting Templates Solvency II Aegon Levensverzekering N.V. This document contains the following quantitative reporting templates (QRTs) which relate to the position at 31 December

More information

Financial Insurance Company Limited

Financial Insurance Company Limited Financial Insurance Company Limited Solvency and Financial Condition Report Disclosures 31 December 2016 (Monetary amounts in GBP thousands) General information Undertaking name Financial Insurance Company

More information

Senior Insurance I Managers Regime (SIMR) The Chief Executive is responsible for allocating each of the SIMR prescribed responsibilities to one or more approved persons in accordance with the PRA Rulebook

More information

2017 Public Quantitative Reporting Templates Solvency II Aegon Levensverzekering N.V.

2017 Public Quantitative Reporting Templates Solvency II Aegon Levensverzekering N.V. 2017 Public Quantitative Reporting Templates Solvency II Aegon Levensverzekering N.V. This document contains the following quantitative reporting templates (QRTs) which relate to the position at 31 December

More information

(Text with EEA relevance)

(Text with EEA relevance) 31.12.2015 L 347/1285 COMMISSION IMPLEMTING REGULATION (EU) 2015/2452 of 2 December 2015 laying down implementing technical standards with regard to the procedures, formats and templates of the solvency

More information

Solvency Assessment and Management (SAM)

Solvency Assessment and Management (SAM) Solvency Assessment and Management (SAM) 1. Solvency Assessment and Management (SAM) The FSB is in the process of developing a new risk-based solvency regime for South African shortterm and long-term insurers,

More information

Technical Specification on the Long Term Guarantee Assessment (Part I)

Technical Specification on the Long Term Guarantee Assessment (Part I) EIOPA-DOC-13/061 28 January 2013 Technical Specification on the Long Term Guarantee Assessment (Part I) This document contains part I of the technical specifications for the long-term guarantees assessment

More information

Sparebank 1 Skadeforsikring AS

Sparebank 1 Skadeforsikring AS Sparebank 1 Skadeforsikring AS Solvency and Financial Condition Report Disclosures 31 December 2017 (Monetary amounts in NOK thousands) General information Undertaking name Sparebank 1 Skadeforsikring

More information

SOLVENCY II Level 2 Implementing Measures

SOLVENCY II Level 2 Implementing Measures SOLVENCY II Level 2 Implementing Measures Position after the 3 waves of Consultation Papers and the Quantitative Impact Study 5 Technical Specifications Dr. Thomas Guidon CASUALTY LOSS RESERVE SEMINAR

More information

1. INTRODUCTION AND PURPOSE

1. INTRODUCTION AND PURPOSE Solvency Assessment and Management: Pillar I - Sub Committee Capital Requirements Task Group Discussion Document 61 (v 1) SCR standard formula: Operational Risk EXECUTIVE SUMMARY 1. INTRODUCTION AND PURPOSE

More information

Appendix 2: Supervisory Statements

Appendix 2: Supervisory Statements Appendix 2: Supervisory Statements Transposition of Solvency II: Part 3 August 2014 1 Appendix 2.1 Supervisory Statement SS[xx]/14 Solvency II: general application August 2014 Prudential Regulation Authority

More information

Lancashire Insurance Company (UK) Ltd

Lancashire Insurance Company (UK) Ltd Lancashire Insurance Company (UK) Ltd Solvency and Financial Condition Report Disclosures 31 December 2017 (Monetary amounts in USD thousands) General information Undertaking name Lancashire Insurance

More information

Quantitative reporting templates Appendix Verslag over de solvabiliteit en de financiële toestand Loyalis Leven 2017

Quantitative reporting templates Appendix Verslag over de solvabiliteit en de financiële toestand Loyalis Leven 2017 Quantitative reporting templates 2017 Appendix Verslag over de solvabiliteit en de financiële toestand Loyalis Leven 2017 2017 Inhoud Balance sheet....3 Premiums, claims and expenses by line of business....5

More information

EIOPA s first set of advice to the European Commission on specific items in the Solvency II Delegated Regulation

EIOPA s first set of advice to the European Commission on specific items in the Solvency II Delegated Regulation EIOPA-BoS-17/280 30 October 2017 EIOPA s first set of advice to the European Commission on specific items in the Solvency II Delegated Regulation EIOPA Westhafen Tower, Westhafenplatz 1-60327 Frankfurt

More information

Consultation Paper on the draft proposal for Guidelines on reporting and public disclosure

Consultation Paper on the draft proposal for Guidelines on reporting and public disclosure EIOPA-CP-14/047 27 November 2014 Consultation Paper on the draft proposal for Guidelines on reporting and public disclosure EIOPA Westhafen Tower, Westhafenplatz 1-60327 Frankfurt Germany - Tel. + 49 69-951119-20;

More information

OHRA Ziektekostenverzekeringen N.V.

OHRA Ziektekostenverzekeringen N.V. OHRA Ziektekostenverzekeringen N.V. Solvency and Financial Condition Report 2017 disclosure templates (Amount x 1.000) Content of submission s.02.01 Balance Sheet s.05.01 Premiums, claims and expenses

More information

Quantitave reporting templates Appendix SFCR Leven. jij, je pensioen en

Quantitave reporting templates Appendix SFCR Leven. jij, je pensioen en Quantitave reporting templates 2016 Appendix SFCR Leven jij, je pensioen en Inhoud Balance sheet.... 3 Life... 5 Home Country - life.... 6 Life and Health SLT Technical Provisions.... 7 Impact of long

More information

2.1 Pursuant to article 18D of the Act, an authorised undertaking shall, except where otherwise provided for, value:

2.1 Pursuant to article 18D of the Act, an authorised undertaking shall, except where otherwise provided for, value: Valuation of assets and liabilities, technical provisions, own funds, Solvency Capital Requirement, Minimum Capital Requirement and investment rules (Solvency II Pillar 1 Requirements) 1. Introduction

More information

Solvency and financial condition report 2017

Solvency and financial condition report 2017 Solvency and financial condition report 2017 The Standard Life Assurance Company 2006 Contents Summary 2 A Business and performance 4 A.1 Business 4 A.2 Underwriting performance 5 A.3 Investment performance

More information

Aioi Nissay Dowa Insurance Company of Europe Limited

Aioi Nissay Dowa Insurance Company of Europe Limited Aioi Nissay Dowa Insurance Company of Europe Limited Solvency and Financial Condition Report Disclosures 31 December 2016 (Monetary amounts in GBP thousands) General information Undertaking name Aioi Nissay

More information

Hong Kong RBC First Quantitative Impact Study

Hong Kong RBC First Quantitative Impact Study Milliman Asia e-alert 1 17 August 2017 Hong Kong RBC First Quantitative Impact Study Introduction On 28 July 2017, the Insurance Authority (IA) of Hong Kong released the technical specifications for the

More information

29th India Fellowship Seminar

29th India Fellowship Seminar 29th India Fellowship Seminar Is Risk Based Capital way forward? Adaptability to Indian Context & Comparison of various market consistent measures Guide: Sunil Sharma Presented by: Rakesh Kumar Niraj Kumar

More information

Delta Lloyd Zorgverzekering N.V.

Delta Lloyd Zorgverzekering N.V. Delta Lloyd Zorgverzekering N.V. Solvency and Financial Condition Report 2017 disclosure templates (Amount x 1.000) Content of submission s.02.01 Balance Sheet s.05.01 Premiums, claims and expenses by

More information

Report on long-term guarantees measures and measures on equity risk

Report on long-term guarantees measures and measures on equity risk EIOPA REGULAR USE EIOPA-BoS-17/334 20 December 2017 Report on long-term guarantees measures and measures on equity risk 2017 1/171 Table of Contents Executive summary... 3 I. Introduction... 6 I.1 Review

More information

Solvency II: Implementation Challenges & Experiences Learned

Solvency II: Implementation Challenges & Experiences Learned Solvency II: Implementation Challenges & Experiences Learned Appointed Actuary Symposium Actuarial Society of Hong Kong (ASHK) Jonathan Zhao - Actuarial Services Practice Leader, Asia Pacific 3 November

More information

Index-linked and unit-linked insurance Other life insurance Annuities stemming from non-life insurance. Contracts with options or guarantees

Index-linked and unit-linked insurance Other life insurance Annuities stemming from non-life insurance. Contracts with options or guarantees S.12.1.2 Life and Health SLT Technical Provisions Insurance with profit participation Indexlinked and unitlinked Other life Annuities stemming from nonlife Contracts without options and guarantees Contracts

More information

User Guide for Input Spreadsheet QIS on IORPs

User Guide for Input Spreadsheet QIS on IORPs Updated 15 November 2012 User Guide for Input Spreadsheet QIS on IORPs Contents 1. Introduction... 2 2. Overview of spreadsheet... 2 3. Participant information... 4 4. Current regime... 5 5. Holistic balance

More information

Using Solvency II to implement IFRS 17

Using Solvency II to implement IFRS 17 www.pwc.co.uk 4 Using Solvency II to implement IFRS 17 September 2017 How can you make the best use of existing Solvency II systems and processes to ensure as smooth and efficient a transition to IFRS

More information

Challenger Life Company Limited Comparability of capital requirements across different regulatory regimes

Challenger Life Company Limited Comparability of capital requirements across different regulatory regimes Challenger Life Company Limited Comparability of capital requirements across different regulatory regimes 26 August 2014 Challenger Life Company Limited Level 15 255 Pitt Street Sydney NSW 2000 26 August

More information

S Balance sheet Solvency II value

S Balance sheet Solvency II value S.02.01.02(A,S) Balance sheet S.02.01.02.01 Balance sheet Solvency II value C0010 Assets Goodwill R0010 Deferred acquisition costs R0020 Intangible assets R0030 0 k Deferred tax assets R0040 870 k Pension

More information

1. INTRODUCTION AND PURPOSE

1. INTRODUCTION AND PURPOSE Solvency Assessment and Management: Pillar 1 Sub Committee Capital Requirements Task Group Discussion Document 74 (v 3) Minimum Capital Requirement (MCR) EXECUTIVE SUMMARY Having compared the IAIS ICPs

More information

CEIOPS-Secretariat Committee of European Insurance and Occupational Pensions Supervisors Westhafenplatz Frankfurt am Main Germany

CEIOPS-Secretariat Committee of European Insurance and Occupational Pensions Supervisors Westhafenplatz Frankfurt am Main Germany CEIOPS-Secretariat Committee of European Insurance and Occupational Pensions Supervisors Westhafenplatz 1 60327 Frankfurt am Main Germany The European Insurance CFO Forum Solvency II Working Group C/O

More information

Compromise proposal on Omnibus II

Compromise proposal on Omnibus II Compromise proposal on Omnibus II On 25 November 2013 a compromise proposal on the Omnibus II Directive was published. This was based on a provisional agreement from the European Parliament, the European

More information

Solvency II and the Work of CEIOPS

Solvency II and the Work of CEIOPS The Geneva Papers, 2008, 33, (60 65) r 2008 The International Association for the Study of Insurance Economics 1018-5895/08 $30.00 www.palgrave-journals.com/gpp Solvency II and the Work of CEIOPS Thomas

More information

Regulatory Consultation Paper Round-up

Regulatory Consultation Paper Round-up Regulatory Consultation Paper Round-up Both the PRA and EIOPA have issued consultation papers in Q4 2017 - some of the changes may have a significant impact for firms if they are implemented as currently

More information

Karel VAN HULLE. Head of Unit, Insurance and Pensions, DG Markt, European Commission

Karel VAN HULLE. Head of Unit, Insurance and Pensions, DG Markt, European Commission Solvency II: State of Play Guernsey, 18th December 2009 Karel VAN HULLE Head of Unit, Insurance and Pensions, DG Markt, European Commission 1 Why do we need Solvency II? Lack of risk sensitivity in existing

More information

solvency and financial condition report - disclosure ASR Aanvullende Ziektekostenverzekeringen N.V. (Monetary amounts in thousands)

solvency and financial condition report - disclosure ASR Aanvullende Ziektekostenverzekeringen N.V. (Monetary amounts in thousands) 2016 solvency and financial condition report - disclosure ASR Aanvullende Ziektekostenverzekeringen N.V. (Monetary amounts in thousands) S.02.01.02 - Balance sheet 2 2016 Solvency II Value Assets Intangible

More information

OWM CZ groep Aanvullende verzekering Zorgverzekeraar U.A.

OWM CZ groep Aanvullende verzekering Zorgverzekeraar U.A. OWM CZ groep Aanvullende verzekering Zorgverzekeraar U.A. Solvency and Financial Condition Report 2017 disclosure templates (Amount x 1.000) Content of submission s.02.01 Balance Sheet s.05.01 Premiums,

More information

De Friesland Zorgverzekeraar N.V. Openbaar te maken QRT's

De Friesland Zorgverzekeraar N.V. Openbaar te maken QRT's De Friesland Zorgverzekeraar N.V. Openbaar te maken QRT's 2016 S.02.01.02 - Balance sheet 1.000 Assets Solvency II value Intangible assets 0 Deferred tax assets 0 Pension benefit surplus 0 Property, plant

More information

Solvency II Interpreting the key principles

Solvency II Interpreting the key principles Solvency II Interpreting the key principles Contents Introduction 2 Pillar I: solvency capital requirements 5 Pillar II: general regulatory principles 7 Pillar III: financial disclosure and solvency 9

More information

Annex I S Balance sheet Solvency II value Assets

Annex I S Balance sheet Solvency II value Assets S.02.01.02 Balance sheet Solvency II value Assets C0010 Intangible assets R0030 - Deferred tax assets R0040 80,694,193 Pension benefit surplus R0050 53,827,400 Property, plant & equipment held for own

More information

Technical Specification for the Preparatory Phase (Part I)

Technical Specification for the Preparatory Phase (Part I) EIOPA-14/209 30 April 2014 Technical Specification for the Preparatory Phase (Part I) This document contains part I of the technical specifications for the preparatory phase. It needs to be applied in

More information

De Friesland Particuliere Ziektekostenverzekeringen N.V. Openbaar te maken QRT's

De Friesland Particuliere Ziektekostenverzekeringen N.V. Openbaar te maken QRT's De Friesland Particuliere Ziektekostenverzekeringen N.V. Openbaar te maken QRT's 2016 S.02.01.02 - Balance sheet 1.000 Assets Solvency II value Intangible assets 0 Deferred tax assets 0 Pension benefit

More information

AVÉRO ACHMEA ZORGVERZEKERINGEN N.V. Openbaar te maken QRT's

AVÉRO ACHMEA ZORGVERZEKERINGEN N.V. Openbaar te maken QRT's AVÉRO ACHMEA ZORGVERZEKERINGEN N.V. Openbaar te maken QRT's 2016 S.02.01.02 - Balance sheet 1.000 Assets Solvency II value Intangible assets 0 Deferred tax assets 0 Pension benefit surplus 0 Property,

More information

Solvency II. Insurance and Pensions Unit, European Commission

Solvency II. Insurance and Pensions Unit, European Commission Solvency II Insurance and Pensions Unit, European Commission Introduction Solvency II Deepened integration of the EU insurance market 14 existing Directives on insurance and reinsurance supervision, insurance

More information

CEIOPS-SEC-78/10 25 May 2010 CEIOPS Comments on QIS5 draft technical specifications

CEIOPS-SEC-78/10 25 May 2010 CEIOPS Comments on QIS5 draft technical specifications CEIOPS-SEC-78/10 25 May 2010 CEIOPS Comments on QIS5 draft technical specifications 1. Following the submission by CEIOPS of its draft technical specifications for QIS5 and the publication on 15 April

More information

Society of Actuaries in Ireland Solvency II for Beginners. Mike Frazer. 19 May 2011

Society of Actuaries in Ireland Solvency II for Beginners. Mike Frazer. 19 May 2011 Society of Actuaries in Ireland Solvency II for Beginners Mike Frazer 19 May 2011 1 Agenda Why has Solvency II been created? Structure of Solvency II The Solvency II Balance Sheet Pillar II & III Aspects

More information

2. The European insurance sector

2. The European insurance sector 2. The European insurance sector 2.1. Market share and growth The relative size of the insurance sector differs substantially among European countries (Figure 2.1). 18 19 As a share of the economy, Luxembourg

More information

N.V. Hagelunie. Openbaar te maken QRT's

N.V. Hagelunie. Openbaar te maken QRT's N.V. Hagelunie Openbaar te maken QRT's 216 S.2.1.2 - Balance sheet 1. Assets Solvency II value Intangible assets Deferred tax assets Pension benefit surplus Property, plant & equipment held for own use

More information

CEA proposed amendments, April 2008

CEA proposed amendments, April 2008 CEA proposed amendments, April 2008 Amendment 1: Recital 14 a (new) The supervision of reinsurance activity shall take account of the special characteristics of reinsurance business, notably its global

More information

Solvency Assessment and Management: Steering Committee Position Paper (v 3) Loss-absorbing capacity of deferred taxes

Solvency Assessment and Management: Steering Committee Position Paper (v 3) Loss-absorbing capacity of deferred taxes Solvency Assessment and Management: Steering Committee Position Paper 112 1 (v 3) Loss-absorbing capacity of deferred taxes EXECUTIVE SUMMARY SAM introduces a valuation basis of technical provisions that

More information

Solvency Assessment and Management: Steering Committee Position Paper (v 4) Life SCR - Retrenchment Risk

Solvency Assessment and Management: Steering Committee Position Paper (v 4) Life SCR - Retrenchment Risk Solvency Assessment and Management: Steering Committee Position Paper 108 1 (v 4) Life SCR - Retrenchment Risk EXECUTIVE SUMMARY This document discusses the structure and calibration of the proposed Retrenchment

More information

Verslag inzake de Solvabiliteit en de Financiële Toestand bedragen in duizenden. DSW Ziektekostenverzekeringen N.V.

Verslag inzake de Solvabiliteit en de Financiële Toestand bedragen in duizenden. DSW Ziektekostenverzekeringen N.V. Verslag inzake de Solvabiliteit en de Financiële Toestand 217 bedragen in duizenden DSW Ziektekostenverzekeringen N.V. Inhoudsopgave: 2.1 Balance Sheet 5.1 Premiums, claims and expenses by line of business

More information

LONGEVITY SWAPS. Impact of Solvency II AN EFFECTIVE, INNOVATIVE WAY TO MANAGE THE LONGEVITY RISK. Presenter: Tom O Sullivan, F.S.A, F.C.I.A, M.A.A.A.

LONGEVITY SWAPS. Impact of Solvency II AN EFFECTIVE, INNOVATIVE WAY TO MANAGE THE LONGEVITY RISK. Presenter: Tom O Sullivan, F.S.A, F.C.I.A, M.A.A.A. LONGEVITY SWAPS AN EFFECTIVE, INNOVATIVE WAY TO MANAGE THE LONGEVITY RISK Impact of Solvency II Presenter: Tom O Sullivan, F.S.A, F.C.I.A, M.A.A.A. Date: December 3, 2010 AGENDA 1. Solvency II - Background

More information

2017 Solvency II Public Quantitative Reporting Templates Blue Square Re N.V.

2017 Solvency II Public Quantitative Reporting Templates Blue Square Re N.V. 2017 Solvency II Public Quantitative Reporting Templates Blue Square Re N.V. Blue Square Re N.V. Aegonplein 50 2591 TV The Hague Template Template title code S.02.01 Balance sheet S.05.01 Premiums, claims

More information

S Balance sheet. in thousand EUR. Solvency II value

S Balance sheet. in thousand EUR. Solvency II value Index S.02.01_Balance Sheet S.05.01_Premiums, claims and expenses by line of business S.05.02_Premiums, claims and expenses by country S.12.01_Life and Health SLT Technical Provisions S.22.01_Impact of

More information

Number Date Reference

Number Date Reference Number Date Reference 1 28/09/2015 0 2 28/09/2015 Preparatory phase reporting template S.34.01.g 3 08/12/2015 S.34.01 Final Solvency II template 4 19/01/2016 DPM and Taxonomy 2.0.1, Annotated Templates

More information

CEIOPS-DOC-61/10 January Former Consultation Paper 65

CEIOPS-DOC-61/10 January Former Consultation Paper 65 CEIOPS-DOC-61/10 January 2010 CEIOPS Advice for Level 2 Implementing Measures on Solvency II: Partial internal models Former Consultation Paper 65 CEIOPS e.v. Westhafenplatz 1-60327 Frankfurt Germany Tel.

More information

S Balance sheet. in thousand EUR. Solvency II value

S Balance sheet. in thousand EUR. Solvency II value Index S.02.01_Balance Sheet S.05.01_Premiums, claims and expenses by line of business S.05.02_Premiums, claims and expenses by country S.17.01_Non - life Technical Provisions S.19.01_Non-life Insurance

More information

AVIVA Solvency and Financial Condition Report ( SFCR )

AVIVA Solvency and Financial Condition Report ( SFCR ) AVIVA 2016 Solvency and Financial Condition Report ( SFCR ) 2 Disclaimer Cautionary statements: This should be read in conjunction with the documents distributed by Aviva plc (the Company or Aviva ) through

More information

1. INTRODUCTION AND PURPOSE 2. DEFINITIONS

1. INTRODUCTION AND PURPOSE 2. DEFINITIONS Solvency Assessment and Management: Steering Committee Position Paper 28 1 (v 6) Treatment of Expected Profits Included in Future Cash flows as a Capital Resource 1. INTRODUCTION AND PURPOSE An insurance

More information

Solvency Assessment and Management. Report on the results of 1 st South African Quantitative Impact Study ( SA QIS1 )

Solvency Assessment and Management. Report on the results of 1 st South African Quantitative Impact Study ( SA QIS1 ) Solvency Assessment and Management Report on the results of 1 st South African Quantitative Impact Study ( SA QIS1 ) DECEMBER 2011 C O N T A C T D E T A I L S Physical Address: Riverwalk Office Park, Block

More information

Christina Urias SMI Task Force Chair Director, Arizona Department of Insurance

Christina Urias SMI Task Force Chair Director, Arizona Department of Insurance May 21, 2010 TO: Christina Urias SMI Task Force Chair Director, Arizona Department of Insurance FROM: RE: Mary A. Weiss, Ph.D. Distinguished Scholar, CIPR NAIC Country Solvency Comparisons Materials for

More information

S Balance sheet. in EUR. Solvency II value

S Balance sheet. in EUR. Solvency II value S.02.01.02 Balance sheet Solvency II value Assets C0010 Intangible assets R0030 - Deferred tax assets R0040 - Pension benefit surplus R0050 - Property, plant & equipment held for own use R0060 174.280.265

More information

Lancashire Holdings Limited

Lancashire Holdings Limited Lancashire Holdings Limited Solvency and Financial Condition Report Disclosures 31 December 2017 (Monetary amounts in USD thousands) General information Participating undertaking name Lancashire Holdings

More information

Appendix 4b. Individual Results Life Companies. 1 Proposed title

Appendix 4b. Individual Results Life Companies. 1 Proposed title Appendix 4b Individual Results Life Companies 1 Proposed title 1. UNIQA LIFE INSURANCE - SII The Company s Balance Sheet is composed of BGN 81m assets and BGN 65m liabilities leading to excess of assets

More information

Annex I S Balance sheet Solvency II value Assets

Annex I S Balance sheet Solvency II value Assets S.02.01.02 Balance sheet Solvency II value Assets C0010 Intangible assets R0030 0 Deferred tax assets R0040 2 062 111 Pension benefit surplus R0050 0 Property, plant & equipment held for own use R0060

More information

S Balance sheet. in thousand EUR. Solvency II value Assets

S Balance sheet. in thousand EUR. Solvency II value Assets Index S.02.01_Balance Sheet S.05.01_Premiums, claims and expenses by line of business S.05.02_Premiums, claims and expenses by country S.12.01_Life and Health SLT Technical Provisions S.17.01_Non - life

More information

EIOPACP 13/010. Guidelines on Submission of Information to National Competent Authorities

EIOPACP 13/010. Guidelines on Submission of Information to National Competent Authorities EIOPACP 13/010 Guidelines on Submission of Information to National Competent Authorities EIOPA Westhafen Tower, Westhafenplatz 1 60327 Frankfurt Germany Tel. + 49 6995111920; Fax. + 49 6995111919; site:

More information

Recalculation of the Solvency II transitional measures on technical provisions. by IFoA TMTP working party

Recalculation of the Solvency II transitional measures on technical provisions. by IFoA TMTP working party Recalculation of the Solvency II transitional measures on technical provisions by IFoA TMTP working party 7 August 2017 Disclaimer; The views expressed in this publication are those of invited contributors

More information

Quantitative Impact Study 4 Summary results and main messages

Quantitative Impact Study 4 Summary results and main messages Quantitative Impact Study 4 Summary results and main messages Stakeholder Meeting Frankfurt, 20 October 2008 20/10/2008 Page 1 Agenda Welcome and introductory remarks (by Klaas Knot, Managing Board member)

More information

Tax in Solvency II. Ayesha Patel. 10 June Tel: June 2014

Tax in Solvency II. Ayesha Patel. 10 June Tel: June 2014 Tax in Solvency II Ayesha Patel Email: ayesha.patel@uk.pwc.com Tel: 020 7212 1239 June 2014 10 June 2014 Agenda 1 Background 2 The three Pillars 3 Pillar I in detail 4 Survey 5 Summary 6 Questions 2 Background

More information

Judging the appropriateness of the Standard Formula under Solvency II

Judging the appropriateness of the Standard Formula under Solvency II Judging the appropriateness of the Standard Formula under Solvency II Steven Hooghwerff, AAG Roel van der Kamp, CFA, FRM Sinéad Clarke, FSAI, FIA, BAFS 1 Introduction Solvency II, which went live on January

More information

Solvency and Financial Condition Report for Reporting Period Telenor Forsikring AS

Solvency and Financial Condition Report for Reporting Period Telenor Forsikring AS Solvency and Financial Condition Report for Reporting Period 2016 Telenor Forsikring AS Jan Gunnar Rossvoll/Anthony Kingston May 5 2017 Table of Contents 1. Summary... 3 2. The business and key figures...

More information

ANALYSIS OF THE SOLVENCY AND FINANCIAL CONDITION REPORTS OF EUROPEAN INSURANCE AND REINSURANCE ENTITIES AT 31 DECEMBER 2017 (SFCR 2017)

ANALYSIS OF THE SOLVENCY AND FINANCIAL CONDITION REPORTS OF EUROPEAN INSURANCE AND REINSURANCE ENTITIES AT 31 DECEMBER 2017 (SFCR 2017) ANALYSIS OF THE SOLVENCY AND FINANCIAL CONDITION REPORTS OF EUROPEAN INSURANCE AND REINSURANCE ENTITIES AT 31 DECEMBER 2017 (SFCR 2017) All rights reserved - Mazars - October 2018 Any representation or

More information

Response to EIOPA consultation on corrections and amendments to implementing technical standards on reporting and disclosure

Response to EIOPA consultation on corrections and amendments to implementing technical standards on reporting and disclosure Response to EIOPA consultation on corrections and amendments to implementing technical standards on reporting and disclosure General comments Insurance Europe welcomes the opportunity to comment on the

More information

Capital Adequacy and Supervisory Assessment of Solvency Position

Capital Adequacy and Supervisory Assessment of Solvency Position Capital Adequacy and Supervisory Assessment of Solvency Position Jeffery Yong IAIS Secretariat Regional Seminar for Supervisors in Africa on Risk-based Solvency and Supervision, 14 September 2010 Agenda

More information

Understanding the prudential balance sheet. Lars Dieckhoff Principal expert Solvency II

Understanding the prudential balance sheet. Lars Dieckhoff Principal expert Solvency II Understanding the prudential balance sheet Lars Dieckhoff Principal expert Solvency II Understanding the prudential balance sheet Content Overview of the prudential balance sheet Solvency Capital Requirement

More information

Solvency Monitoring and

Solvency Monitoring and Solvency Monitoring and Reporting Venkatasubramanian A CILA2006/AV 1 Intro No amount of capital can substitute for the capacity to understand, measure and manage risk and no formula or model can capture

More information

Technical Specifications part II on the Long-Term Guarantee Assessment Final version

Technical Specifications part II on the Long-Term Guarantee Assessment Final version EIOPA/12/307 25 January 2013 Technical Specifications part II on the Long-Term Guarantee Assessment Final version Purpose of this document This document contains part II of the technical specifications

More information

Stress Test Exercise Questions & Answers

Stress Test Exercise Questions & Answers EIOPA-FS-11/17 Version 17 May 2011 Stress Test Exercise 2011 Questions & Answers Stress Test - List of Methodological Issues Raised by Participants and Supervisors General Disclaimer The answers given

More information

Achmea Regular Supervisory Report. Achmea Summary Solvency and Financial Condition Report

Achmea Regular Supervisory Report. Achmea Summary Solvency and Financial Condition Report Achmea Regular Supervisory Report Achmea Summary Solvency and Financial Condition Report Solvency and Financial Condition Report Achmea 2017 Summary Solvency and Financial Condition Report 2 Achmea Solvency

More information